One of the mechanisms by which p16INK4a inhibits tumor growth under hypoxic conditions is mediated through the interaction of p16INK4a with CDK4 [8] and a subsequent decrease in CDK4 catalytic activity [18]. The gene discussed is CDKN2A; the disease is neoplasm.